The Effect of Simulation-Based Oxytocin Induction Training on Midwifery Students' Knowledge and Anxiety Levels
24 de agosto de 2026 actualizado por: Melisa Gündeş
This randomized controlled study was conducted to evaluate the effect of simulation-based oxytocin induction training on midwifery students' knowledge and anxiety levels.
The study population consisted of third-year midwifery students enrolled in the Faculty of Health Sciences at Istanbul Medipol University during the spring semester of the 2024-2025 academic year.
Eligible students who volunteered to participate were randomly assigned to an intervention group or a control group.
Both groups received theoretical training on oxytocin induction management.
In addition to the theoretical training, the intervention group received simulation-based oxytocin induction training using a high-fidelity simulator and a standardized patient.
Data were collected between April and May 2025 using the Introductory Information Form, Oxytocin Induction Knowledge Assessment Form, Objective Structured Clinical Evaluation Form, State-Trait Anxiety Inventory, Simulation Design Scale, Student Satisfaction and Self-Confidence in Learning Scale, and Educational Practices Questionnaire.
Descripción general del estudio
Estado
Terminado
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
80
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Beykoz
-
Istanbul, Beykoz, Turquía (Türkiye), 34810
- Istanbul Medipol University, Faculty of Health Sciences
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Being enrolled as a third-year undergraduate student in the Department of Midwifery, Faculty of Health Sciences, Istanbul Medipol University, during the spring semester of the 2024-2025 academic year
- Having successfully completed the Childbirth and Postpartum Period course
- Having successfully completed the Childbirth and Postpartum Period Clinical Practice course
- Having a cumulative grade point average of 2.70 or higher
- Volunteering to participate in the study
- Providing written and verbal informed consent
Exclusion Criteria:
- Not meeting one or more of the inclusion criteria
- Declining to participate in the study
- Not providing written or verbal informed consent
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Theoretical Training + Simulation-Based Training
Participants in this arm received theoretical training on oxytocin induction.
In addition to the theoretical training, they received simulation-based oxytocin induction training using high-fidelity simulation and a standardized patient.
|
Participants received theoretical training covering the principles and clinical management of oxytocin induction.
Following the theoretical training, participants in the intervention group received simulation-based training on oxytocin induction management using a high-fidelity simulator and a standardized patient.
|
|
Comparador activo: Theoretical Training
Participants in this arm received theoretical training on oxytocin induction and did not receive the additional simulation-based training.
|
Participants received theoretical training covering the principles and clinical management of oxytocin induction.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Oxytocin Induction Knowledge Score
Periodo de tiempo: At baseline, before theoretical training, and 5 weeks after theoretical training
|
Knowledge of oxytocin induction was assessed using the 28-item Oxytocin Induction Knowledge Assessment Form.
Each item was answered as "True," "False," or "I do not know."
Correct answers were scored as 1, while incorrect answers and "I do not know" responses were scored as 0. The total score ranged from 0 to 28, with higher scores indicating a higher level of knowledge regarding oxytocin induction and its management.
Changes in total knowledge scores between baseline and follow-up assessments were evaluated.
|
At baseline, before theoretical training, and 5 weeks after theoretical training
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in State Anxiety Score
Periodo de tiempo: At baseline, before theoretical training, and 5 weeks after theoretical training
|
State anxiety was assessed using the State Anxiety subscale of the State-Trait Anxiety Inventory.
The subscale consists of 20 items and produces a total score ranging from 20 to 80, with higher scores indicating higher levels of state anxiety.
The change in total state anxiety score between the assessment time points was evaluated.
|
At baseline, before theoretical training, and 5 weeks after theoretical training
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
11 de noviembre de 2024
Finalización primaria (Actual)
26 de mayo de 2025
Finalización del estudio (Actual)
26 de mayo de 2025
Fechas de registro del estudio
Enviado por primera vez
2 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
24 de agosto de 2026
Publicado por primera vez (Actual)
26 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
26 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
24 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- E-10840098-202.3.02-7862
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .